“Medication is a tool — not a shortcut.” – Jason Jacobson

In this episode of Compound Wisdom, Steve Sood sits down with Jason Jacobson, emergency-trained nurse practitioner and founder of Slim Wellness, to break down what most telehealth companies get wrong about weight loss, hormones, and long-term metabolic care.

Jason’s path into medicine wasn’t linear. A high school dropout who rebuilt his life through tech, sales, and eventually emergency medicine, he now splits his time between the ER, academia, and a brick-and-mortar clinic designed to counter the “prescription-first” telehealth model

Slim Wellness was sparked by a personal catalyst. After watching his bonus daughter gain significant weight following birth control and struggle to find real answers, Jason saw firsthand how mainstream clinics default to surface-level solutions — especially once GLP-1s entered the spotlight

. His response was to build a provider-led, high-touch platform centered on root-cause analysis rather than transactional prescribing.

The conversation moves beyond generic weight loss talk and into structural care gaps: why “eat less, move more” is often clinical laziness, how PCOS is frequently mishandled, and why hormones sit at the center of metabolic dysfunction

Jason outlines the four pillars he prioritizes in PCOS treatment — inflammation, hormones, nutrition, and movement — and explains why most women are cycled through algorithms without meaningful personalization

. His model begins with full metabolic labs, narrative-driven intake conversations, and expectation setting that emphasizes time horizon over 30-day transformations.

They also unpack peptides. Jason clarifies what peptides actually are — short amino acid chains that signal native biological processes — and why misunderstanding their mechanism fuels regulatory tension

. The discussion touches on insulin as the earliest peptide example, evolving FDA positions, compounding scrutiny, Ryan Haight Act implications, and the uncertain reclassification environment.

The episode closes with a sober look at telehealth’s future: political volatility, DEA oversight, testosterone regulation, concierge-style differentiation, and the risk of large marketing-driven platforms commoditizing care.

This is a grounded conversation about metabolic medicine, regulatory reality, and what it takes to scale care without sacrificing clinical integrity.

Takeaways

Jason transitioned from tech and sales into emergency medicine before launching Slim Wellness
Slim Wellness was inspired by a personal PCOS and weight-loss journey
Most telehealth platforms prioritize medication over metabolic strategy
PCOS treatment requires addressing inflammation, hormones, nutrition, and movement
“Eat less, move more” without guidance is not a treatment plan
Peptides are signaling molecules, not synthetic tricks
Insulin was one of the earliest peptide therapies
Regulatory shifts around peptides and testosterone could reshape telehealth
Concierge-style access may become a competitive moat
Provider-led continuity of care differentiates from marketing-driven telemedicine

Chapters

00:00 – From high school dropout to emergency medicine

03:00 – Why Slim Wellness was built differently

06:30 – PCOS, hormones, and metabolic root causes

11:00 – The four pillars of PCOS treatment

15:00 – Peptides explained simply

19:00 – Regulatory scrutiny and telehealth uncertainty

23:00 – Concierge care vs scale-first models

27:00 – Hims vs Ro and competitive positioning

29:30 – Blind question and closing

Takeaways

Chapters

Tags

The Problem With One-Prescription Weight Loss Clinics